167 related articles for article (PubMed ID: 10189572)
1. Aerosol deposition modeling using ACSL.
Carpenter RL
Drug Chem Toxicol; 1999 Feb; 22(1):73-90. PubMed ID: 10189572
[TBL] [Abstract][Full Text] [Related]
2. A semi-empirical model of aerosol deposition in the human respiratory tract for mouth inhalation.
Gonda I
J Pharm Pharmacol; 1981 Nov; 33(11):692-6. PubMed ID: 6118406
[TBL] [Abstract][Full Text] [Related]
3. Uncertainty in particulate deposition for 1 microm AMAD particles in an adult lung model.
Harvey RP; Hamby DM
Radiat Prot Dosimetry; 2001; 95(3):239-47. PubMed ID: 11605798
[TBL] [Abstract][Full Text] [Related]
4. Multicomponent aerosol particle deposition in a realistic cast of the human upper respiratory tract.
Nordlund M; Belka M; Kuczaj AK; Lizal F; Jedelsky J; Elcner J; Jicha M; Sauser Y; Le Bouhellec S; Cosandey S; Majeed S; Vuillaume G; Peitsch MC; Hoeng J
Inhal Toxicol; 2017 Feb; 29(3):113-125. PubMed ID: 28470142
[TBL] [Abstract][Full Text] [Related]
5. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
[TBL] [Abstract][Full Text] [Related]
6. Bridging inhaled aerosol dosimetry to physiologically based pharmacokinetic modeling for toxicological assessment: nicotine delivery systems and beyond.
Kolli AR; Kuczaj AK; Martin F; Hayes AW; Peitsch MC; Hoeng J
Crit Rev Toxicol; 2019 Oct; 49(9):725-741. PubMed ID: 31903848
[TBL] [Abstract][Full Text] [Related]
7. Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways.
Tian G; Longest PW; Su G; Hindle M
Ann Biomed Eng; 2011 Mar; 39(3):1136-53. PubMed ID: 21152983
[TBL] [Abstract][Full Text] [Related]
8. Deposition Mechanisms.
Darquenne C
J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):181-185. PubMed ID: 32598200
[TBL] [Abstract][Full Text] [Related]
9. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
[TBL] [Abstract][Full Text] [Related]
10. Mathematical model for the selective deposition of inhaled pharmaceuticals.
Martonen TB
J Pharm Sci; 1993 Dec; 82(12):1191-9. PubMed ID: 8308694
[TBL] [Abstract][Full Text] [Related]
11. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
12. Deconvolution of Systemic Pharmacokinetics Predicts Inhaled Aerosol Dosimetry of Nicotine.
Kolli AR; Calvino-Martin F; Kuczaj AK; Wong ET; Titz B; Xiang Y; Lebrun S; Schlage WK; Vanscheeuwijck P; Hoeng J
Eur J Pharm Sci; 2023 Jan; 180():106321. PubMed ID: 36336278
[TBL] [Abstract][Full Text] [Related]
13. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
[TBL] [Abstract][Full Text] [Related]
14. SPECT/CT study of bronchial deposition of inhaled particles. A human aerosol vaccination model against HPV.
Ilic V; Dunet V; Le Pape A; Buchs M; Kosinski M; Bischof Delaloye A; Gerber S; Prior JO
Nuklearmedizin; 2016 Sep; 55(5):203-8. PubMed ID: 27440125
[TBL] [Abstract][Full Text] [Related]
15. Modeling the dose distribution of H2SO4 aerosols in the human tracheobronchial tree.
Martonen TB; Patel M
Am Ind Hyg Assoc J; 1981 Jun; 42(6):453-60. PubMed ID: 7293923
[TBL] [Abstract][Full Text] [Related]
16. DEVELOPMENT OF CALCULATION TOOL FOR RESPIRATORY TRACT DEPOSITION DEPENDING ON AEROSOLS PARTICLE DISTRIBUTION.
Iwaoka K; Hosoda M; Tokonami S; Enriquez EB; Palad LJH; Kanda R
Radiat Prot Dosimetry; 2019 Oct; 184(3-4):388-390. PubMed ID: 31329999
[TBL] [Abstract][Full Text] [Related]
17. A mathematical model of bronchial absorption of vapors in the human lung and its significance in pharmacokinetic modeling.
Shelley ML; Harris RL; Boehlecke BA
SAR QSAR Environ Res; 1996; 5(4):221-53. PubMed ID: 9104782
[TBL] [Abstract][Full Text] [Related]
18. Deposition of naphthalene and tetradecane vapors in models of the human respiratory system.
Zhang Z; Kleinstreuer C
Inhal Toxicol; 2011 Jan; 23(1):44-57. PubMed ID: 21222561
[TBL] [Abstract][Full Text] [Related]
19. Computation of ammonium bisulfate aerosol deposition in conducting airways.
Martonen TB; Patel M
J Toxicol Environ Health; 1981; 8(5-6):1001-14. PubMed ID: 7338937
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SPECT aerosol deposition data with a human respiratory tract model.
Fleming JS; Epps BP; Conway JH; Martonen TB
J Aerosol Med; 2006; 19(3):268-78. PubMed ID: 17034303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
